Your browser doesn't support javascript.
loading
Phase III trial of consolidation therapy with yttrium-90-ibritumomab tiuxetan compared with no additional therapy after first remission in advanced follicular lymphoma.
J Clin Oncol ; 26(32): 5156-64, 2008 Nov 10.
Article in En | MEDLINE | ID: mdl-18854568

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Lymphoma, Follicular / Radioimmunotherapy / Antibodies, Monoclonal Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: America do norte / Europa Language: En Journal: J Clin Oncol Year: 2008 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Lymphoma, Follicular / Radioimmunotherapy / Antibodies, Monoclonal Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: America do norte / Europa Language: En Journal: J Clin Oncol Year: 2008 Document type: Article Affiliation country: